Target Gene Table ▼
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10059244HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10060158HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10059245HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10060157HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10060156HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10060628HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10060785HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TVIS10060627HBVENSG00000158874.12protein_codingAPOA2NoNo336P02652
TCGA Plot Options ▼
Drug Information ▼
GeneAPOA2
DrugBank IDDB01593
Drug NameZinc
Target IDBE0000922
UniProt IDP02652
Regulation Type
PubMed IDs23896426
CitationsWang F, Chmil C, Pierce F, Ganapathy K, Gump BB, MacKenzie JA, Metchref Y, Bendinskas K: Immobilized metal affinity chromatography and human serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:26-33. doi: 10.1016/j.jchromb.2013.06.032. Epub 2013 Jul 5.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Zn]
PathwaysDihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia
PharmGKBPA451956
ChEMBLCHEMBL1201279